D
Sell
3/14/2023Downgrade
RxSight, Inc. (RXST) was downgraded to D- from D on 3/14/2023 due to a decline in the valuation index.
D
Sell
2/23/2023Upgraded
RxSight, Inc. (RXST) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index, total return index and valuation index.
D
Sell
2/8/2023Downgrade
RxSight, Inc. (RXST) was downgraded to D- from D on 2/8/2023 due to a large decline in the efficiency index, volatility index and solvency index. The quick ratio declined from 10.43 to 7.44, debt to equity increased from 0.38 to 0.44, and total capital declined 9.18% from $155.56M to $141.29M.
D
Sell
8/1/2022Upgraded
RxSight, Inc. (RXST) was upgraded to D from D- on 8/1/2022 due to an increase in the volatility index and total return index.
D
Sell
4/1/2022Upgraded
RxSight, Inc. (RXST) was upgraded to D- from E on 4/1/2022 due to an increase in the volatility index, growth index and total return index. Total revenue increased 45.63% from $5.79M to $8.43M, operating cash flow increased 36.59% from -$13.76M to -$8.72M, and earnings per share increased from -$0.68 to -$0.5759.
E
Sell
1/3/2022Upgraded
RxSight, Inc. (RXST) was upgraded to E from E- on 1/3/2022 due to a significant increase in the solvency index, growth index and total return index. The quick ratio increased from 5.91 to 18.81, earnings per share increased from -$3.526 to -$0.68, and total revenue increased 18.15% from $4.9M to $5.79M.
E
Sell
10/22/2021None
RxSight, Inc. (RXST) was downgraded to E- from U on 10/22/2021.
